For many years the standard treatment of DVT and PE has been daily injections of one type of anticoagulant called a Heparin, together with tablets of a second anticoagulant called a vitamin K antagonist (Warfarin), for the initial treatment period. Thereafter, a single treatment with Warfarin. This standard treatment for DVT and PE is highly effective, but it does have a number of limitations. These include the need for injections, and the interaction of vitamin K antagonists with a number of common foods and with other medicines.
New oral medications are now available for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE that does not require frequent testing and dosage changes, and no significant food interactions.
Disclaimer
This e-brochure has been auto-translated for your convenience. While machine translations are helpful, they may contain errors. Medinformer is actively working to have all translations reviewed by professional, mother-tongue language speakers, though this process will take time. For the most accurate information, please refer to the original English version. Medinformer and its partners cannot be held responsible for any inaccuracies that may result from the translation.
Thank you for your understanding.